Aarti Drugs can move to Rs 200 in the next 6 months, says SP Tulsian of sptulsian.com. Their Q1 earnings came well. They posted a topline of Rs 190 crore and EPS of Rs 7.90 for the quarter, while EPS for whole of FY12 was close to Rs 18 or maybe sub-Rs 18.
first published: Sep 4, 2012 10:36 am
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.